Ping L - Search Results

1

ITK inhibition induced in vitro and in vivo anti-tumor activity through downregulating TCR signaling pathway in malignant T cell lymphoma.

Liu Y, Wang X, Deng L, Ping L, Shi Y, Zheng W, Lin N, Wang X, Tu M, Xie Y, Liu W, Ying Z, Zhang C, Pan Z, Wang X, Ding N, Song Y, Zhu J. Liu Y, et al. Among authors: ping l. Cancer Cell Int. 2019 Feb 14;19:32. doi: 10.1186/s12935-019-0754-9. eCollection 2019. Cancer Cell Int. 2019. PMID: 30814910 Free PMC article.

2

[Central nervous system lymphoma and its significance].

Zheng W, Lin NJ, Xie Y, Wang XP, Tu MF, Liu WP, Song YQ, Ping LY, Ying ZT, Deng LJ, Zhang C, Zhu J. Zheng W, et al. Zhonghua Yi Xue Za Zhi. 2011 Jun 14;91(22):1550-4. Zhonghua Yi Xue Za Zhi. 2011. PMID: 21914369 Chinese.

3

[Plasma levels of VEGF-C, VEGF-D, VEGFR-2 and VEGFR-3 in patients with newly diagnosed lymphomas].

Liu F, Song YQ, Zhang C, Fu ZY, Ping LY, Ying ZT, Zheng W, Wang XP, Xie Y, Lin NJ, Tu MF, Zhu J. Liu F, et al. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2011 Oct;19(5):1184-8. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2011. PMID: 22040968 Chinese.

4

[An analysis of hepatitis B virus infection rate in 405 cases of non-Hodgkin lymphoma].

Liu WP, Zheng W, Wang XP, Song YQ, Xie Y, Tu MF, Lin NJ, Ping LY, Ying ZT, Deng LJ, Zhang C, Zhu J. Liu WP, et al. Zhonghua Xue Ye Xue Za Zhi. 2011 Aug;32(8):521-4. Zhonghua Xue Ye Xue Za Zhi. 2011. PMID: 22338173 Chinese.

5

The clinical features, therapeutic responses, and prognosis of the patients with mantle cell lymphoma.

Ying ZT, Zheng W, Wang XP, Xie Y, Tu MF, Lin NJ, Ping LY, Liu WP, Deng LJ, Zhang C, Zhu J, Song YQ. Ying ZT, et al. Chin J Cancer. 2012 Jul;31(7):348-53. doi: 10.5732/cjc.011.10469. Epub 2012 Jun 14. Chin J Cancer. 2012. PMID: 22704490 Free PMC article.

6

[Prognostic value of maximum standard uptake on pretreatment 18F-FDG PET/CT scan in newly diagnosed diffuse large B cell lymphoma].

Ying ZT, Wang XJ, Song YQ, Zheng W, Wang XP, Xie Y, Lin NJ, Tu MF, Ping LY, Liu WP, Deng LJ, Zhang C, Yang Z, Zhu J. Ying ZT, et al. Zhonghua Yi Xue Za Zhi. 2012 Dec 11;92(46):3246-9. Zhonghua Yi Xue Za Zhi. 2012. PMID: 23328506 Chinese.

7

[Safety and adverse event profiling of pegylated L-asparaginase combined chemotherapy in the treatment of lymphoma].

Ping LY, Zheng W, Wang XP, Xie Y, Lin NJ, Tu MF, Ying ZT, Zhang C, Liu WP, Deng LJ, Zhu J, Song YQ. Ping LY, et al. Zhonghua Yi Xue Za Zhi. 2012 Dec 11;92(46):3257-60. Zhonghua Yi Xue Za Zhi. 2012. PMID: 23328509 Chinese.

8

Prognostic value of interim (18)F-FDG PET/CT in diffuse large B-cell lymphoma.

Ying Z, Wang X, Song Y, Zheng W, Wang X, Xie Y, Lin N, Tu M, Ping L, Liu W, Deng L, Zhang C, Yang Z, Zhu J. Ying Z, et al. Among authors: ping l. Chin J Cancer Res. 2013 Feb;25(1):95-101. doi: 10.3978/j.issn.1000-9604.2013.01.08. Chin J Cancer Res. 2013. PMID: 23372347 Free PMC article.

9

[Prognostic value of (18)F-FDG PET/CT after first-line treatment in patients with diffuse large B cell lymphoma].

Ying ZT, Wang XJ, Song YQ, Zheng W, Wang XP, Xie Y, Lin NJ, Tu MF, Ping LY, Liu WP, Deng LJ, Zhang C, Yang Z, Zhu J. Ying ZT, et al. Zhonghua Xue Ye Xue Za Zhi. 2012 Oct;33(10):810-3. Zhonghua Xue Ye Xue Za Zhi. 2012. PMID: 23384899 Chinese.

10

A prospective phase II study of L-asparaginase- CHOP plus radiation in newly diagnosed extranodal NK/T-cell lymphoma, nasal type.

Lin N, Song Y, Zheng W, Tu M, Xie Y, Wang X, Ping L, Ying Z, Zhang C, Deng L, Liu W, Zhu J. Lin N, et al. Among authors: ping l. J Hematol Oncol. 2013 Jul 1;6:44. doi: 10.1186/1756-8722-6-44. J Hematol Oncol. 2013. PMID: 23816178 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

601 results

Search Page

Filters